Sep 11, 2023 / 08:15PM GMT
Erin Elizabeth Wilson Wright - Morgan Stanley, Research Division - Equity Analyst
Hi. Good afternoon, everybody. My name is Erin Wright. I'm the lead health care services analyst at Morgan Stanley. We're happy to have with us today Elanco Animal Health. We have the management team here. We have Jeff Simmons, the CEO with us up on the podium here and then also Todd Young in the audience, the CFO; and IR, Katy Grissom as well, who leads up the IR effort there. So happy to have you. I'm glad you can come and welcome, I think I hand it to you for just some intro remarks, if you want to give those and then we can hop right into Q&A.
Jeffrey N. Simmons - Elanco Animal Health Incorporated - President, CEO & Director
Great. Thank you, everybody. Thanks for the interest in Elanco. So I think the headline is we are at an inflection point as a company, second largest independent animal health company. Next year will be our 70th year as a company, longest-standing brand in front of farmers, vets and pet owners. And we really are coming into kind of a historical time.
Elanco Animal Health Inc at Morgan Stanley Global Healthcare Conference Transcript
Feb 10, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers